News | February 05, 2015

Computer Program Helps Doctors Gauge Blood Flow During Aneurysm Treatment

Software compares images to track blood flow in real-time

ISET, aneurysms, blood flow, software, flow diverter, FFR catheters

February 5, 2015 — A new computer program allows doctors to assess blood flow as they are using flow-diverter devices to treat life-threatening aneurysms, suggests a preliminary study being presented at the 27th annual International Symposium on Endovascular Therapy (ISET).

 “Until now, there was no safe way to measure the blood flow in real-time, during the procedure, including flow reduction to the aneurysm and flow to the rest of the brain,” said Aichi Chien, Ph.D., assistant professor of interventional neuroradiology at the University of California, Los Angeles. “Because the program quantifies blood flow automatically, doctors do not need to stop the procedure to get this information, which helps them make the best decisions during the procedure.”

A flow diverter is a small stent made of a fine mesh that is implanted minimally invasively in an artery at the site of an aneurysm. A flow diverter redirects blood past the aneurysm to remove the pressure that could cause the aneurysm to rupture, and the patient to potentially bleed to death. Flow diverters typically are used to treat large (2-2½ centimeters) or giant (more than 2½ centimeters) aneurysms, or those with wide necks.

The Intracranial Stent Flow Mapping computer program — IS FlowMap — takes advantage of the standard digital subtraction angiography (DSA) imaging being taken during the procedure. The program analyzes the standard images, compares the difference in blood flow image to image and calculates the changes within seconds, providing that information to the doctor during treatment. If blood flow isn’t optimal, the doctor may choose to use a different treatment, such as placing coils in the aneurysm.

In the study, 13 patients were treated, and the average reduction in blood flow entering the aneurysm was 48 percent. The flow diverter healed the aneurysm in 11 (85 percent) of the patients.

While 3 to 5 million people in the United States have brain aneurysms, most don’t cause problems. About 30,000 people a year suffer from a ruptured aneurysm. Anyone can develop an aneurysm, but risk factors include high blood pressure, alcohol and drug abuse and smoking.

“There are many advances in devices to treat patients with aneurysms and other vascular disease, but the technology to see the effects of those devices is very limited,” said Chien. “The IS FlowMap provides a simple way to analyze the treatment without any additional procedures or risk. We’ll be able to use this information moving forward to compare treatment and determine what amount of blood flow change is optimal.”

For more information: www.iset.org

Related Content

The CathWorks angiography image derived FFR assessment system has received national reimbursement approval in Japan. The system uses a rotational angiography image dataset taken while the patient is in the cath lab to quickly reconstruct a 3-D coronary tree showing FFR numbers for all of the artery segments. 

The CathWorks angiography image derived FFR assessment system has received national reimbursement approval in Japan. The system uses a rotational angiography image dataset taken while the patient is in the cath lab to quickly reconstruct a 3-D coronary tree showing FFR numbers for all of the artery segments. 

News | FFR Technologies | July 26, 2021
July 26, 2021 – CathWorks announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the
An example of HeartFlow's FFR-CT analysis of blockage severity in a patient's coronary vessels based on a cardiac CT scan.

An example of HeartFlow's FFR-CT analysis of blockage severity in a patient's coronary vessels based on a cardiac CT scan.

News | FFR Technologies | July 15, 2021
July 15, 2021 — HeartFlow, which has commercialized noninvasive...
The Philips Healthcare SyncVision system co-registers iFR hemodynamic blood flow measurements to live angiograms to enable easier assessment of which lesions in a vessel need to be stented and which can be left alone and treated medically.

The Philips Healthcare SyncVision system co-registers iFR hemodynamic  blood flow measurements to live angiograms to enable easier assessment of which lesions in a vessel need to be stented and which can be left alone and treated medically.

News | FFR Technologies | June 22, 2021
June 22, 2021 – Philips Healthcare announced the official start of the DEFINE GPS study, with the first patient being
The FLOWER-MI trial presented at ACC 2021 found no benefit to FFR-guided PCI in STEMI with multi-vessel disease. #ACC21 #ACC2021 #FFR

The FLOWER-MI trial presented at ACC 2021 found no benefit to FFR-guided PCI in STEMI with multi-vessel disease.

News | FFR Technologies | May 17, 2021
May 17, 2021 — In patients who received a coronary stent for an ST-elevation myocardial infarction (STEMI) heart atta
Videos | FFR Technologies | December 16, 2020
This is an example of the Medis Medical Imaging Quantitative Flow Ratio (QFR) system that offers a...
The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease.

The Medis Quantitative Flow Ratio (QFR) is a novel, non-invasive, angiography-based physiologic FFR-like assessment of the presence and extent of coronary artery disease. 

News | FFR Technologies | December 16, 2020
December 16, 2020 – Acist Medical Systems Inc.
Angiography with a co-registered view of pressure drops according iFR readings in a coronary vessel. The DEFINE PCI study showed patients had improved outcomes and less recurrent chest pain at one year using iFR physiologic measurements combined with landmarks shown on angiographic imaging to better guide therapy. Image by Philips Healthcare. #TCT #TCT2020 #TCTconnect

Angiography with a co-registered view of pressure drops according iFR readings in a coronary vessel. The DEFINE PCI study showed patients had improved outcomes and less recurrent chest pain at one year using iFR physiologic measurements combined with landmarks shown on angiographic imaging to better guide therapy. Image by Philips Healthcare

Feature | FFR Technologies | October 30, 2020 | Dave Fornell, Editor
Fractional flow reserve (FFR) is considered the gold standard measure whether a coronary lesions needs a percutaneous
Example of FFR assessment of the coronary hemodynamic flow in lesions using the Philips FFR, iFR assessment system. #FFR #TCTconnect #TCT2020

FFR assessment of a coronary lesion using the Philips Healthcare Volcano FFR system.

News | FFR Technologies | October 23, 2020
October 23, 2020 – A new observational study of deferred lesions following combined fractional flow reserve (FFR) and
Fractional Flow reserve (FFR) selection on the Abbott, St. Jude FFR system console. The TARGET FFR study at #TCT2020 #TCTconnect.
News | FFR Technologies | October 23, 2020
October 23, 2020 – Results from the randomized controlled TARGET FFR trial show that while a physiology-guided percut
An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone actually was not flow limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings. #TCT2020 #TCTconnect

An example of a HeartFlow FFR-CT image showing the blood flow through what looked like a significant blockage on CT angiography alone, actually was not flow-limiting based on computational fluid dynamics. Use of the technology was supposed to reduce the number of diagnostic catheterizations in the FORECAST trial, but the costs of FFR-CT were not offset enough to show cost savings.

News | FFR Technologies | October 22, 2020 | Dave Fornell, Editor
October 22, 2020 – In the FORECAST randomized clinical trial, the use of ...